Andrew Romeo, MD
Neurological Surgery · Mobile, ALNPI 1699064329
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (40.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Medtronic at 56.8% of the total. Reporting peaked in 2019 at $6,382 and has fallen 90.8% since, to $589 in 2025.
Across 106 payments — averaging $117.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Inspire Medical Systems, Inc.$2K
- Abbott$1K
- DIXI Medical USA Corp$833
- Globus Medical$818
- Neuropace, Inc.$253
- plus $563 from 11 others
What the payments were for
- Grants$5,00040%
- Travel & lodging$1,89315%
- Food & beverage$4,87639%
- Education$6845%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 38 | $7,071 |
| Inspire Medical Systems, Inc. | 15 | $1,577 |
| Abbott | 28 | $1,337 |
| DIXI Medical USA Corp | 1 | $833 |
| Globus Medical | 1 | $818 |
| Neuropace, Inc. | 4 | $253 |
| Livanova USA, Inc. | 2 | $155 |
| Boston Scientific | 4 | $95 |
| Baxter Healthcare | 4 | $79 |
| AbbVie | 2 | $65 |
| Integra Lifesciences Corporation | 1 | $35 |
| DJO, LLC | 1 | $30 |
| UCB, Inc. | 1 | $24 |
| Smith+Nephew | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Stryker | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIVA$5,684
- Inspire$1,159
- Excelsius3D Imaging System$818
- Infinity DBS Pulse Generators$345
- INFINITY$292
- PERCEPT PC BRAINSENSE$284
- VISUALASE$131
- RNS System$125
- VNS - Sentiva$125
- CD HORIZON$116
- Proclaim IPG$103
How this compares
$12,452 in reported general payments places this provider in the 85th percentile of 97 neurological surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $222 |
| Oxycodone Hcl | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Mobile
- Richard MengerMobile$70K
- Amber GordonMobile$24K
- William FairclothMobile$6K
- Anthony MartinoMobile$6K
- John AmburgyMobile$5K
- Donald TylerMobile$5K
- Shawn ClarkMobile$4K
- Marc ManixMobile$3K
- Nidal OmarMobile$2K
- Jeremy AmpsMobile$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.